Home/Hedge Fund Intelligence/Maze Therapeutics, Inc.
Nasdaq: MAZEStockForm 13F30 Jun 2026

Hedge funds that hold Maze Therapeutics, Inc. Nasdaq: MAZE

CUSIP 578784100 · who reports it, how much, and how much it matters to them

29 of the 720 hedge fund managers we track reported shares of Maze Therapeutics, Inc. (Nasdaq: MAZE) on Form 13F for 30 June 2026. Between them they reported USD 405m. The largest position belongs to Deep Track Capital, at USD 111m. The manager with the most riding on it is Logos Global Management, where it is 2.5% of the reported book.

Managers reporting it29of 720 we track
Value they reportUSD 405mshares only, 30 Jun 2026
Funds they run382with a file on PPLI.com
Largest positionUSD 111mDeep Track Capital
Typical weight0.1%median share of a manager's book
Heaviest weight2.5%Logos Global Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

29 managers, USD 405m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Maze Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Deep Track Capital1 fund on PPLI.comUSD 111m1.6%
2Logos Global Management1 fund on PPLI.comUSD 58m2.5%
3Braidwell12 funds on PPLI.comUSD 34m1.3%
4Farallon Capital Management56 funds on PPLI.comUSD 33m0.2%
5Marshall Wace LLP84 funds on PPLI.comUSD 27m0.0%
6Citadel Advisors32 funds on PPLI.comUSD 25m0.0%
7Casdin Capital3 funds on PPLI.comUSD 25m1.3%
8Arrowmark Colorado Holdings24 funds on PPLI.comUSD 23m1.0%
9Sphera Funds Management1 fund on PPLI.comUSD 12m1.6%
10Hudson Bay Capital Management8 funds on PPLI.comUSD 8.1m0.0%
11Adage Capital Management1 fund on PPLI.comUSD 7.4m0.0%
12RTW Investments2 funds on PPLI.comUSD 6.3m0.1%
13Two Sigma Investments35 funds on PPLI.comUSD 5.8m0.0%
14Boothbay Fund Management2 funds on PPLI.comUSD 5.6m0.1%
15Exoduspoint Capital Management7 funds on PPLI.comUSD 5.5m0.0%
16HighVista Strategies27 funds on PPLI.comUSD 4.1m0.9%
17Walleye Capital8 funds on PPLI.comUSD 3.8m0.0%
18Exome Asset Management2 funds on PPLI.comUSD 3.4m2.1%
19Dafna Capital Management6 funds on PPLI.comUSD 1.9m0.4%
20Balyasny Asset Management25 funds on PPLI.comUSD 602,0000.0%
21Squarepoint Ops7 funds on PPLI.comUSD 580,0000.0%
22Verition Fund Management3 funds on PPLI.comUSD 543,0000.0%
23Verdad Advisers6 funds on PPLI.comUSD 377,0000.4%
24Jain Global1 fund on PPLI.comUSD 365,0000.0%
25D. E. Shaw & Co.15 funds on PPLI.comUSD 359,0000.0%
26Engineers Gate Manager1 fund on PPLI.comUSD 333,0000.0%
27Entrypoint Capital1 fund on PPLI.comUSD 293,0000.1%
28Persistent Asset Partners10 funds on PPLI.comUSD 200,0000.1%
29The Quarry1 fund on PPLI.comUSD 4,9240.0%
Next: where it matters most
Where it matters most

For Logos Global Management it is 2.5% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Logos Global ManagementUSD 58m2.5%
2Exome Asset ManagementUSD 3.4m2.1%
3Sphera Funds ManagementUSD 12m1.6%
4Deep Track CapitalUSD 111m1.6%
5Casdin CapitalUSD 25m1.3%
6BraidwellUSD 34m1.3%
7Arrowmark Colorado HoldingsUSD 23m1.0%
8HighVista StrategiesUSD 4.1m0.9%
9Dafna Capital ManagementUSD 1.9m0.4%
10Verdad AdvisersUSD 377,0000.4%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Maze Therapeutics, Inc.

What is the ticker symbol of Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. trades under the symbol MAZE on the Nasdaq. Its CUSIP, the code used on Form 13F, is 578784100.

Which hedge funds own Maze Therapeutics, Inc. (Nasdaq: MAZE)?

29 of the 720 hedge fund managers PPLI.com tracks reported Maze Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Deep Track Capital (USD 111m), Logos Global Management (USD 58m), Braidwell (USD 34m), Farallon Capital Management (USD 33m) and Marshall Wace LLP (USD 27m).

How many hedge funds hold Maze Therapeutics, Inc.?

29 managers in our coverage reported it, and between them they run 382 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Maze Therapeutics, Inc.?

Logos Global Management, where the position was 2.5% of the reported 13F book at 30 June 2026.

Does this show who is short Maze Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Maze Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.